Yuriko Ogawa
Akita University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yuriko Ogawa.
Neuroscience Letters | 1996
Yasushi Saito; Tetsuo Shimizu; Yuji Takahashi; Kazuo Mishima; Kenichi Takahashi; Yuriko Ogawa; Susumu Kogawa; Yasuo Hishikawa
To evaluate the effect of bright light on the sympathetic nervous system in human, muscle sympathetic nerve activity (MSNA) was recorded from the peroneal nerve in five healthy subjects. Each subject was exposed to bright light of 5000 lx for 20 min. After the bright light exposure, MSNA became significantly enhanced. The heart rate increased transiently only during the bright light exposure. The blood pressure did not change significantly during and after the bright light exposure. The result is the first direct evidence showing that bright light modulates the activity of the sympathetic nervous system in normal human.
Psychiatry and Clinical Neurosciences | 2002
Rika Aizawa; Takashi Kanbayashi; Yasushi Saito; Yuriko Ogawa; Tomonari Sugiyama; Tsuyoshi Kitajima; Yoshihiko Kaneko; Masahito Abe; Tetsuo Shimizu
Abstract Yoku‐kan‐san‐ka‐chimpi‐hange (YKCH) is a drug used for insomnia in Japanese traditional herbal medicine. The present study evaluated the effects of YKCH on sleep by all‐night polysomnography using the double‐blind method. Yoku‐kan‐san‐ka‐chimpi‐hange increased the total sleep time significantly, and tended to cause an increase in sleep efficiency and of stage 2 sleep, as well as a decrease of sleep latency and of stage 3 + 4 sleep. There was no apparent influence on rapid eye movement (REM) sleep. In terms of non‐REM sleep, the effects of YKCH exhibit a profile similar to those of benzodiazepines.
Neuroscience Letters | 2004
Tsuyoshi Kitajima; Takashi Kanbayashi; Yasushi Saito; Yuji Takahashi; Yuriko Ogawa; Tomonari Sugiyama; Yoshihiko Kaneko; Rika Aizawa; Tetsuo Shimizu
It is known that benzodiazepines have a hypotensive effect, but the mechanism has not been well elucidated yet. To clarify whether this effect is due to central or peripheral mechanism, we administered 5 mg of diazepam or saline intravenously to healthy volunteers and assessed the change in blood pressure, heart rate, muscle sympathetic nerve activity and heart rate variability. After diazepam administration, systolic and mean blood pressure decreased significantly. Muscle sympathetic nerve activity was also significantly reduced but heart rate did not change, whereas the variables of spectral analysis of heart rate variability did not show significant change. We concluded that the hypotensive effect of diazepam in human is mainly due to the central mechanism.
Psychiatry and Clinical Neurosciences | 2001
Tsuyoshi Kitajima; Takashi Kanbayashi; Yasushi Saitoh; Yuriko Ogawa; Tomonari Sugiyama; Yoshihiko Kaneko; Yoshiko Sasaki; Rika Aizawa; Tetsuo Shimisu
We investigated the influence of melatonin on the human autonomic functions by measuring muscle sympathetic nerve activity (MSNA). Five healthy male volunteers took 3 mg of melatonin, and their plasma melatonin concentration, blood pressure, heart rate, and burst rate of MSNA were then recorded. The peak level of melatonin concentration showed a marked interindividual variation. Blood pressure was reduced significantly, while heart rate and burst rate of MSNA did not change significantly. These results indicate that melatonin has a hypotensive effect on blood pressure, and the central cardiovascular regulatory mechanism such as lowering of the baroreflex setpoint would be involved in the effect.
Psychiatry and Clinical Neurosciences | 2002
Takashi Kanbayashi; Hideaki Ishiguro; Rika Aizawa; Yasushi Saito; Yuriko Ogawa; Masahito Abe; Kouichi Hirota; Seiji Nishino; Tetsuo Shimizu
Abstract It is reported that cerebrospinal fluid (CSF) hypocretin‐1 (orexin‐A) concentrations in patients with narcolepsy are significantly low. Human narcolepsy is also known to be closely associated with a specific human histocompatibility leukocyte antigen (HLA), suggesting that autoimmunity is involved in the pathophysiology of the disease. Thus, it is important to know whether hypocretin changes are found in definite neuroimmunological diseases such as multiple sclerosis and Guillain–Barré syndrome (GBS). The results of the present study indicate that some patients with GBS have lower levels of CSF hypocretin‐1.
Journal of Sleep Research | 2003
T. Kanbayashi; Yuichi Inoue; K. Kawanishi; H. Takasaki; Rika Aizawa; K. Takahashi; Yuriko Ogawa; M. Abe; Yasuo Hishikawa; Tetsuo Shimizu
The majority of patients with narcolepsy‐cataplexy were reported to have very low cerebrospinal fluid (CSF) hypocretin‐1 (orexin‐A) levels. The hypocretin‐1 levels of secondary excessive daytime sleepiness (EDS) disorders are not known. In this study, we found that CSF hypocretin levels in the patients with obstructive sleep apnea syndrome were within the control range. The low hypocretin levels seem to reflect only the presence of cataplexy and DR2 positive in narcoleptics but not EDS itself.
Psychiatry and Clinical Neurosciences | 2002
Takashi Kanbayashi; Tomonari Sugiyama; Rika Aizawa; Yasushi Saito; Yuriko Ogawa; Tsuyoshi Kitajima; Yoshihiko Kaneko; Masahito Abe; Tetsuo Shimizu
Abstract Donepezil (Aricept) is a therapeutic drug for the treatment of Alzheimer’s disease (AD). However, there have been only two reports describing the effects of donepezil on sleep as assessed by nocturnal polysomnography (PSG). With this in mind, the effects of donepezil on the sleep of healthy subjects was evaluated using PSG. The results indicated that the percentage of rapid eye movement sleep to total sleep time was increased significantly by a single dose of 5 mg of donepezil when given to healthy subjects immediately before retiring to bed.
Sleep Medicine | 2001
Takashi Kanbayashi; Atsuko Goto; Yasuo Hishikawa; Yuji Takahashi; Yasushi Saito; Yuriko Ogawa; Junya Sugawara; Goro Takada; Tetsuo Shimizu
A 5-year-old girl suffering from hypersomnia due to acute disseminated encephalomyelitis (ADEM) is reported. Brain CT revealed a large low-density lesion involving the lentiform nucleus, posterior limb of the internal capsule, thalamus, posterior hypothalamus and midbrain in the left side. She was treated with intravenous dexamethazone. After the initial dose of dexamethazone, hypersomnia was dramatically and rapidly improved. A later brain CT study disclosed that the lesion in the brain disappeared. The brain lesion in this case involved the waking center in the brain, which was described by Von Economo. We concluded that hypersomnia in this case was due to ADEM involving the neural mechanism for maintaing wakefulness, probably in the thalamus and posterior hypothalamus. Repeat all night polysomnograpy in this case disclosed prolonged total sleep time and increased amount of stage 3-4 sleep in the hypersomniac state.
Psychiatry and Clinical Neurosciences | 1998
Yuji Takahashi; Tetsuo Shimizu; Kenichi Takahashi; Yasushi Saito; Yuriko Ogawa; Takashi Kanbayashi; Yasuo Hishikawa
Abstract A case of adult onset myopathy who showed a peculiar sleep‐related respiratory disorder (SRRD) is reported. She recovered from respiratory failure after tracheostomy and/or with the aid of the respirator used only during the night. Sleep study without the use of respirator revealed that her sleep was highly fragmented by frequent arousal responses due to inspiratory effort but not by apnea or hypopnea. To our knowledge this type of SRRD has not been described.
Sleep | 2003
Yuriko Ogawa; Takashi Kanbayashi; Yasushi Saito; Yuji Takahashi; Tsuyoshi Kitajima; Kenichi Takahashi; Yasuo Hishikawa; Tetsuo Shimizu